SCHEMBL5220800

SCHEMBL5220800

COC(=O)c1cc(NC2CCCC2)cc(N2CCCC2=O)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.51
SMN1; SMN2 Q16637 5/20 0.51
RAB9A P51151 5/20 0.51
HPGD P15428 4/20 0.49
TSHR P16473 3/20 0.49
TP53 P04637 1/20 0.49
MAPK1 P28482 1/20 0.49
CTSD P07339 4/20 0.45
BACE1 P56817 4/20 0.45
BACE2 Q9Y5Z0 4/20 0.45
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
GAA P10253 1/20 0.44
CYP3A4 P08684 2/20 0.44
CYP2C9 P11712 2/20 0.44
ALDH1A1 P00352 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C19 P33261 1/20 0.43
MAPT P10636 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5224335 0.99 NPC1 (0.53) NPC1SMN1; SMN2RAB9AHPGDTSHR
SCHEMBL5223517 0.89 NPC1 (0.54) NPC1SMN1; SMN2RAB9AHPGDTSHR
SCHEMBL5221612 0.88 NPC1 (0.56) NPC1SMN1; SMN2RAB9AHPGDTSHR
SCHEMBL5219444 0.83 MEN1 (0.56) NPC1SMN1; SMN2RAB9AHPGDTSHR
SCHEMBL475775 0.83 MEN1 (0.56) NPC1SMN1; SMN2RAB9AHPGDTSHR
SCHEMBL5222325 0.81 GAA (0.50) NPC1SMN1; SMN2RAB9AHPGDTSHR
SCHEMBL5222197 0.81 GAA (0.63) NPC1SMN1; SMN2RAB9AHPGDTSHR
SCHEMBL5223014 0.81 CTSD (0.48) NPC1SMN1; SMN2RAB9AHPGDTSHR
SCHEMBL5249254 0.81 NPC1 (0.47) NPC1SMN1; SMN2RAB9AHPGDTSHR
SCHEMBL5249518 0.80 SMN1; SMN2 (0.49) NPC1SMN1; SMN2RAB9AHPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567488-B1 HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE GLAXO GROUP LTD (GB) 2007-02-21 EP disclosed